Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New approaches toward anti-HIV chemotherapy.

× No keyword cloud information.

47 in total

1. 3,4,5-Trisubstituted-1,2,4-4H-triazoles as WT and Y188L mutant HIV-1 non-nucleoside reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses.

Authors: Elena Cichero; Laura Buffa; Paola Fossa
Journal: J Mol Model Date: 2010-10-05 Impact factor: 1.810

2. Double Variational Binding--(SMILES) Conformational Analysis by Docking Mechanisms for Anti-HIV Pyrimidine Ligands.

Authors: Mihai V Putz; Nicoleta A Dudaș; Adriana Isvoran
Journal: Int J Mol Sci Date: 2015-08-18 Impact factor: 5.923

3. HIV integrase inhibitors with nucleobase scaffolds: discovery of a highly potent anti-HIV agent.

Authors: Vasu Nair; Guochen Chi; Roger Ptak; Nouri Neamati
Journal: J Med Chem Date: 2006-01-26 Impact factor: 7.446

4. Molecular docking studies on 4-thiazolidinones as HIV-1 RT inhibitors.

Authors: Ravindra K Rawal; Ashutosh Kumar; Mohammad Imran Siddiqi; Setu B Katti
Journal: J Mol Model Date: 2006-09-13 Impact factor: 1.810

Review 5. Identification of HIV inhibitors guided by free energy perturbation calculations.

Authors: Orlando Acevedo; Zandrea Ambrose; Patrick T Flaherty; Hadega Aamer; Prashi Jain; Somisetti V Sambasivarao
Journal: Curr Pharm Des Date: 2012 Impact factor: 3.116

6. From docking false-positive to active anti-HIV agent.

Authors: Gabriela Barreiro; Joseph T Kim; Cristiano R W Guimarães; Christopher M Bailey; Robert A Domaoal; Ligong Wang; Karen S Anderson; William L Jorgensen
Journal: J Med Chem Date: 2007-10-06 Impact factor: 7.446

7. Potent new antiviral compound shows similar inhibition and structural interactions with drug resistant mutants and wild type HIV-1 protease.

Authors: Yuan-Fang Wang; Yunfeng Tie; Peter I Boross; Jozsef Tozser; Arun K Ghosh; Robert W Harrison; Irene T Weber
Journal: J Med Chem Date: 2007-08-16 Impact factor: 7.446

8. Computational studies of the binding mode and 3D-QSAR analyses of symmetric formimidoester disulfides: a new class of non-nucleoside HIV-1 reverse transcriptase inhibitor.

Authors: Elena Cichero; Sara Cesarini; Andrea Spallarossa; Luisa Mosti; Paola Fossa
Journal: J Mol Model Date: 2008-12-09 Impact factor: 1.810

9. Crystallographic study of a novel subnanomolar inhibitor provides insight on the binding interactions of alkenyldiarylmethanes with human immunodeficiency virus-1 reverse transcriptase.

Authors: Matthew D Cullen; William C Ho; Joseph D Bauman; Kalyan Das; Eddy Arnold; Tracy L Hartman; Karen M Watson; Robert W Buckheit; Christophe Pannecouque; Erik De Clercq; Mark Cushman
Journal: J Med Chem Date: 2009-10-22 Impact factor: 7.446

10. C-2-aryl O-substituted HI-236 derivatives as non-nucleoside HIV-1 reverse-transcriptase inhibitors.

Authors: Roger Hunter; Yassir Younis; Clare I Muhanji; Tanith-Lea Curtin; Kevin J Naidoo; Melissa Petersen; Christopher M Bailey; Aravind Basavapathruni; Karen S Anderson
Journal: Bioorg Med Chem Date: 2008-11-01 Impact factor: 3.641